< Back

October, 2017

NCCN Guideline Endorsement Most Influences Decisions to Include Treatments within Pathways

Oncology Pathways Insight and Evolution    |    Research Released September 2017

NCCN Guideline Endorsement Most Influences Decisions to Include Treatments within Pathways

Pathway providers typically require NCCN guideline endorsement, as a prerequisite for considering a treatment for inclusion within pathways.

Using guidelines as a starting point, multi-specialty pathway provider committees then narrow treatment options through further assessment of various factors including efficacy, safety, real-world experience, and/or value-based framework recommendations.

pathway providors

Download the research slide

 

These and other findings can be found in Health Strategies Group’s recently released research Approaches for Engaging with Oncology Pathway Providers.

Key questions answered in this research:

  • What is the decision criteria for placing a product on pathway?
  • How do pathway providers influence the development and administration of oncology pathways?
  • Which biopharmaceutical companies lead at engaging with pathway provider organizations?

Download Research Agenda

 

Visit our Oncology Pathways Insight and Evolution webpage to learn more about this research.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.